Squarepoint’s Galena Biopharma RXII Stock Holding History
Bought
Maintained
Sold
Other funds holding RXII
Squarepoint's RXII Position: Q1 2016 in Review
Squarepoint sold out of Galena Biopharma (RXII) in Q1 2016, closing a stake of 11,000 shares — an estimated $16K sold.
Squarepoint first reported a position in RXII in Q4 2015 and held it in 1 quarter. The position peaked at $16K in Q4 2015. 71 funds tracked by Wall St. Rank hold RXII as of Q1 2016.
- Squarepoint reported no remaining Galena Biopharma position as of Q1 2016 after selling out during the quarter.
- Squarepoint sold 11,000 Galena Biopharma shares in Q1 2016, an estimated $16K.
- Squarepoint first reported a position in Galena Biopharma in Q4 2015 and held it in 1 quarter.
- Squarepoint's Galena Biopharma position peaked at $16K in Q4 2015.
- 71 funds tracked by Wall St. Rank held Galena Biopharma as of Q1 2016.
Based on Squarepoint's 13F filing for Q1 2016, filed 16 May 2016.